Mail-order pharmacy use and adherence to diabetes-related medications

American Journal of Managed Care

Volumn 16, Issue 1, 2010, Pages 33-40

  Duru, O Kenrik ^a   Schmittdiel, Julie A ^b   Dyer, Wendy T ^b   Parker, Melissa M ^b   Uratsu, Connie S ^b   Chan, James ^c   Karter, Andrew J ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b DIVISION OF RESEARCH   (United States)

^c Pharmacy Outcomes Research Group   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTILIPEMIC AGENT;

ADULT; ARTICLE; CLINICAL PHARMACY; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIABETES MELLITUS; DIABETIC PATIENT; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; PATIENT COMPLIANCE; PRIORITY JOURNAL;

AGED; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS; FEMALE; HUMANS; HYPOGLYCEMIC AGENTS; MALE; MEDICATION ADHERENCE; MIDDLE AGED; PHARMACEUTICAL SERVICES; POSTAL SERVICE;

EID: 75149193151     PISSN: 10880224     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. DiMatteo MR. Variations in patients' adherence to medical recommendations: a quantitative review of 50 years of research. Med Care. 2004;42(3):200-209.
2. Wens J, Van Casteren V, Vermeire E, Van Royen P, Pas L, Denekens J. Diagnosis and treatment of type 2 diabetes in three Belgian regions: registration via a network of sentinel general practices. Eur J Epidemiol. 2001;17(8):743-7'50.
3. Ho PM, Rumsfeld JS, Masoudi FA, et al. Effect of medication nonadherence on hospitalization and mortality among patients with diabetes mellitus. Arch Intern Med. 2006;166(17):1836-1841.
4. Lau DT, Nau DP. Oral antihyperglycemic medication nonadherence and subsequent hospitalization among individuals with type 2 diabetes. Diabetes Care. 2004;27(9):2149-2153.
5. Sokol MC, McGuigan KA, Verbrugge RR, Epstein RS. Impact of medication adherence on hospitalization risk and healthcare cost. Med Care. 2005;43(6):521-530.
6. Feldman R, Bacher M, Campbell N, Drover A, Chockalingam A. Adherence to pharmacologic management of hypertension. Can J Public Health. 1998;89(5):I16-I18.
7. Avom J, Monette J, Lacour A, et al. Persistence of use of lipid-lowering medications: a cross-national study. JAMA. 1998;279(18):1458-1462.
8. Cramer JA. A systematic review of adherence with medications for diabetes. Diabetes Care. 2004;27(5):1218-1224.
9. Odegard PS, Capoccia K. Medication taking and diabetes: a systematic review of the literature. Diabetes Educ. 2007;33(6):1014-1029.
10. Duru OK, Gerzoff RB, Selby JV, et al. Identifying risk factors for racial disparities in diabetes outcomes: the Translating Research Into Action for Diabetes study. Med Care. 2009;47(6):700-706.
11. Valluri S, Seoane-Vazquez E, Rodriguez-Monguio R, Szeinbach SL. Drug utilization and cost in a Medicaid population: a simulation study of community vs. mail order pharmacy. BMC Health Serv Res. 2007;30(7):122.
12. Thomas CP, Wallack SS, Lee S, Ritter GA. Impact of health plan design and management on retirees' prescription drug use and spending, 2001. Health Aff (Millwood). 2002;(suppl Web exclusives):W408-W419.
13. Carroll NV, Brusilovsky I, York B, Oscar R. Comparison of costs of community and mail service pharmacy. J Am Pharm Assoc. 2003;45(3):336-343.
14. Federal Trade Commission. Pharmacy Benefit Managers: Ownership of Mail-Order Pharmacies. Washington, DC: Federal Trade Commission; 2005.
15. Karter AJ, Ferrara A, Liu JY, Moffet HH, Ackerson LM, Selby JV Ethnic disparities in diabetic complications in an insured population [published correction appears in JAMA. 2002;288(1):46]. JAMA. 2002;287(19):2519-2527.
16. Morin N, Litsky P, Miller MG, Likosky W. Population at Risk for Utilization (PARFU): a method for assigning HMO members to specific facilities based on utilization. In: AHSR FHSR Annual Meeting Abstract Book. Oakland, CA: Kaiser Permanente Northern California Region; 1996:55-56.
17. Steiner JF, Koepsell TD, Fihn SD, Inui TS. A general method of compliance assessment using centralized pharmacy records. Med Care. 1988;26(8):814-823.
18. Steiner JF, Prochazka AV. The assessment of refill compliance using pharmacy records: methods, validity, and applications: description and validation. J Clin Epidemiol. 1997;50(1):105-116.
19. Grymonpre R, Cheang M, Fraser M, Metge C, Sitar DS. Validity of a prescription claims database to estimate medication adherence in older persons. Med Care. 2006;44(5):471-477.
20. Messer LC, Laraia BA, Kaufman JS, et al. The development of a standardized neighborhood deprivation index. J Urban Health. 2006;83(6):1041-1062.
21. Terza JV, Bradford WD, Dismuke CE. The use of linear instrumental variables methods in health services research and health economics: a cautionary note. Health Serv Res. 2008;43(3):1102-1120.
22. Greene WH. Gender economics courses in liberal arts colleges: further results. J Econ Educ. 1998;29(4):291-300.
23. Newhouse JP, McClellan M. Econometrics in outcomes research: the use of instrumental variables. Annu Rev Public Health. 1998;19:17-34.
24. Greenland S. An introduction to instrumental variables for epidemiologists. Int J Epidemiol. 2000;29(4):722-729.
25. McClellan M, McNeil BJ, Newhouse JP. Does more intensive treatment of acute myocardial infarction in the elderly reduce mortality? Analysis using instrumental variables. JAMA. 1994;272(11):859-866.
26. Fortney J, Booth B, Zhang M, Humphrey J, Wiseman E. Controlling for selection bias in the evaluation of Alcoholics Anonymous as aftercare treatment. J Stud Alcohol. 1998;59(6):690-697.
27. Fortney J, Rost K, Zhang M, Pyne J. The relationship between quality and outcomes in routine depression care. Psychiatr Serv. 2001;52(1):56-62.
28. Lu M. The productivity of mental health care: an instrumental variable approach. J Ment Health Policy Econ. 1999;2(2):59-71.
29. Cox E, Mager D. Is Compliance Really Better in Home Delivery? Evidence Across Three Chronic Therapy Classes. St Louis, MO: Express Scripts; 2008.
30. Sabate E. Adherence to Long-Term Therapies: Evidence for Action. Geneva, Switzerland: World Health Organization; 2003.
31. Richard C, Lussier MT. Nature and frequency of exchanges on medications during primary care encounters. Patient Educ Couns. 2006;64(1-3):207-216.
32. Tarn DM, Paterniti DA, Heritage J, Hays RD, Kravitz RL, Wenger NS. Physician communication about the cost and acquisition of newly prescribed medications. Am J Manag Care. 2006;12(11):657-664.
33. van Dulmen S, Sluijs E, van Dijk L, de Ridder D, Heerdink R, Bensing J. Patient adherence to medical treatment: a review of reviews. BMC Health Serv Res. 2007;7:e55.
34. McDonald HP, Garg AX, Haynes RB. Interventions to enhance patient adherence to medication prescriptions: scientific review [published correction appears in JAMA. 2003;289(24):3242]. JAMA. 2002;288(22):2868-2879.
35. Haynes RB, Ackloo E, Sahota N, McDonald HP, Yao X. Interventions for enhancing medication adherence. Cochrane Database Syst Rev. 2008;(2):CD000011.
36. Lee JK, Grace KA, Taylor AJ. Effect of a pharmacy care program on medication adherence and persistence, blood pressure, and low-density lipoprotein cholesterol: a randomized controlled trial. JAMA. 2006;296(21):2563-2571.
37. Murray MD, Young J, Hoke S, et al. Pharmacist intervention to improve medication adherence in heart failure: a randomized trial. Ann Intern Med. 2007;146(10):714-725.
38. Bunting BA, Smith BH, Sutherland SE. The Asheville Project: clinical and economic outcomes of a community-based long-term medication therapy management program for hypertension and dyslipidemia. J Am Pharm Assoc (2003). 2008;48(1):23-31.
39. American College of Clinical Pharmacy. A vision of pharmacy's future roles, responsibilities, and manpower needs in the United States. Pharmacotherapy. 2000;20(8):991-1020.
40. Christensen DB, Farris KB. Pharmaceutical care in community pharmacies: practice and research in the US. Ann Pharmacother. 2006;40(7-8):1400-1406.
41. US Government Accountability Office. Mail Order Pharmacies: DOD's Use of VA's Mail Pharmacy Could Produce Savings and Other Benefits: Report to the Chairman, Subcommittee on Oversight and Investigations, Committee on Veterans' Affairs, House of Representatives. Washington, DC: US Government Accountability Office; 2005. Publication GAO-05-555.